Terbogrel
98%
- Product Code: 102871
CAS:
149979-74-8
| Molecular Weight: | 405.49 g./mol | Molecular Formula: | C₂₃H₂₇N₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Terbogrel is primarily investigated for its potential therapeutic applications in the management of cardiovascular diseases. It functions as a thromboxane synthase inhibitor and thromboxane receptor antagonist, making it effective in preventing platelet aggregation and vasoconstriction. This dual mechanism of action suggests its utility in conditions like myocardial infarction, unstable angina, and other thrombotic disorders. By reducing the formation of thromboxane A2, it helps improve blood flow and decrease the risk of clot formation in patients with arterial diseases. Additionally, its antiplatelet properties make it a candidate for use in conjunction with other anticoagulant therapies to enhance efficacy in preventing cardiovascular events. Research continues to explore its broader applications in treating pulmonary hypertension and other vascular disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿172,800.00 |
+
-
|
| 0.005 | 10-20 days | ฿388,800.00 |
+
-
|
Terbogrel
Terbogrel is primarily investigated for its potential therapeutic applications in the management of cardiovascular diseases. It functions as a thromboxane synthase inhibitor and thromboxane receptor antagonist, making it effective in preventing platelet aggregation and vasoconstriction. This dual mechanism of action suggests its utility in conditions like myocardial infarction, unstable angina, and other thrombotic disorders. By reducing the formation of thromboxane A2, it helps improve blood flow and decrease the risk of clot formation in patients with arterial diseases. Additionally, its antiplatelet properties make it a candidate for use in conjunction with other anticoagulant therapies to enhance efficacy in preventing cardiovascular events. Research continues to explore its broader applications in treating pulmonary hypertension and other vascular disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :